Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed)
Agency: National Institutes of Health
- 93.351 -- Research Infrastructure Programs
- 93.989 -- International Research and Research Training
- 93.113 -- Environmental Health
- 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
- 93.173 -- Research Related to Deafness and Communication Disorders
- 93.121 -- Oral Diseases and Disorders Research
- 93.837 -- Cardiovascular Diseases Research
- 93.233 -- National Center on Sleep Disorders Research
- 93.846 -- Arthritis, Musculoskeletal and Skin Diseases Research
- 93.839 -- Blood Diseases and Resources Research
- 93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
- 93.867 -- Vision Research
- 93.213 -- Research and Training in Complementary and Integrative Health
- 93.838 -- Lung Diseases Research
- 93.393 -- Cancer Cause and Prevention Research
- 93.321 -- Dietary Supplement Research Program
- 93.866 -- Aging Research
- 93.865 -- Child Health and Human Development Extramural Research
- 93.273 -- Alcohol Research Programs
- 93.855 -- Allergy and Infectious Diseases Research
- 93.237 -- Special Diabetes Program for Indians Diabetes Prevention and Treatment Projects
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
This Funding Opportunity Announcement (FOA) announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological. Additionally, ODS supports research and training programs that build future research capacity for studying the role of dietary supplements in health and disease prevention. Primary consideration for support will be given to applications that stimulate dietary supplement research where it is lacking or lagging, clarify gaps, opportunities and balance between benefits and risks where data are in conflict, target special population groups where additional science on dietary supplements is needed, and focus on the use of dietary supplements in improving or maintaining health and reducing the risk of chronic disease. This FOA will not support new clinical trials.
Eligibility
Eligible applicants
Business
- Small businesses
- For-profit organizations other than small businesses
Nonprofit
- Other Native American tribal organizations
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
Miscellaneous
- Other
Government
- State governments
- Special district governments
- Federally recognized Native American tribal governments
- City or township governments
- Public and Indian housing authorities
- County governments
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Additional information
Grantor contact information
Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Documents
No documents are currently available.
Link to additional information
Archived: July 9, 2020
Award
$--
Program Funding
--
Expected awards
$--
Award Minimum
$100,000
Award Maximum
Funding opportunity number:
PA-18-817
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Income security and social services
Health
Food and nutrition
Education
Environment
Category Explanation:
History
Version:
3
Posted date:
June 5, 2018
Archive date:
July 9, 2020
